Transdermal contraceptive formulations, methods and devices
December 17, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3598122 3598123 3710795 Novel drug delivery device Ɗ15 -Steroids and pharmaceutical compositions thereof Medicament carriers in the form of film having active substance incorporated therein Device consisting of copolymer having acetoxy groups for delivering drugs Therapeutic system for administering drugs to the skin Polymeric diffusion matrix containing estradiol diacetate Dissolution controlled active agent dispenser InventorsAssigneeApplicationNo. 994055 filed on 12/17/1992US Classes:424/448, Pressure sensitive adhesive means424/449, Transdermal or percutaneous514/843, Female (mammal)514/947Topical applicationExaminersPrimary: Phelan, D. GabrielleAttorney, Agent or FirmForeign Patent References
International ClassA61F 013/02AbstractThe present invention provides compositions and methods for the transdermal administration of a contraceptively effective amount of gestodene and an estrogen, such as ethinyl estradiol, in combination, together with a suitable permeation enhancer.Other References
| |
